Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Operating Expenses (2024 - 2025)

Beta Bionics' Operating Expenses history spans 2 years, with the latest figure at $35.1 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 41.83% year-over-year to $35.1 million; the TTM value through Dec 2025 reached $127.2 million, up 56.79%, while the annual FY2025 figure was $127.2 million, 56.79% up from the prior year.
  • Operating Expenses for Q4 2025 was $35.1 million at Beta Bionics, up from $32.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $35.1 million in Q4 2025 and bottomed at $16.7 million in Q1 2024.